Placental lactogen (HPL)
450 UAH
Hormonal panel/Prenatal diagnosis
Placental lactogen (HPL) and its role in hormonal panel and prenatal diagnosis
Placental lactogen (HPL) is one of the key hormones produced by the placenta during pregnancy. This hormone plays an important role in the maintenance and development of pregnancy and is of great importance in hormonal panels and prenatal diagnosis.
HPL is a glycoprotein synthesized by placental cells, especially those that form the outer layer of the placenta. This hormone is produced in large quantities early in pregnancy and increases in concentration as pregnancy progresses. The main functions of HPL include:
- Metabolic regulation: HPL promotes glucose redistribution in the mother and maintains appropriate blood sugar levels, providing the fetus with the energy it needs for growth and development.
- Stimulation of fetal growth: This hormone increases the amount of fat in the mother's tissues, which promotes the growth of the fetus and provides it with nutrients.
- Support for high chest mass: HPL helps prepare the mother's mammary glands for lactation, promoting their increase in size.
- Antagonism to other hormones: HPL reduces the mother's sensitivity to insulin, which helps maintain appropriate blood glucose levels.
In a hormone panel used to monitor pregnancy and assess fetal and maternal health, HPL may be included as one of the indicators. High levels of HPL may indicate a normal pregnancy, while low levels may indicate possible problems.
In prenatal diagnosis, HPL is also used to identify possible abnormalities in fetal development. High levels of HPL in certain cases may be associated with the risk of preterm birth, gestational diabetes, or hypertension. Testing HPL levels in the middle and late trimesters of pregnancy can help detect these conditions in time and develop a treatment or pregnancy management strategy.
Overall, placental lactogen plays a key role in the hormonal panel and prenatal diagnosis of pregnancy. Determining the level of this hormone allows for early detection of potential problems and ensuring appropriate medical intervention to preserve the health of both the mother and the fetus.
| Execution time |
1 day |
|---|---|
| Type of biomaterial |
Venous blood |

